FLGT — Fulgent Genetics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSuper Stock

Annual balance sheet for Fulgent Genetics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	299	450	526	424	258
Net Total Accounts Receivable
Net Total Receivables	204	143	75.1	57.4	77
Prepaid Expenses
Total Other Current Assets
Total Current Assets	524	612	628	508	354
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	41	71.2	98.9	95.6	112
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	700	1,279	1,386	1,235	1,220
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	130	105	88.1	73	72.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	131	120	119	99.2	86.7
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	569	1,159	1,267	1,136	1,133
Total Liabilities & Shareholders' Equity	700	1,279	1,386	1,235	1,220
Total Common Shares Outstanding